Literature DB >> 34031555

Cognitive functioning of older adults prior to hematopoietic stem cell transplantation.

Maureen Lacy1, Mandy Fong2, Corey Bolton3, Michael Maranzano4, Michael Bishop5, Andrew Artz6.   

Abstract

Hematopoietic cell transplantation is increasingly used in older adults with hematological malignancies. Younger adult patients who undergo HCT have shown to commonly present with cognitive impairment and depression prior to transplant; however, little research has been done to understand the cognitive and emotional functioning of older adults undergoing HCT. This study aimed to investigate the rate of cognitive impairment in a retrospective sample of older adult HCT candidates prior to transplant using a comprehensive battery. Ninety-three patients over the age of 60 completed a neuropsychology test battery that assessed standard domains of cognitive and emotional functioning. Impairment was defined as z-scores = < -1.5 on at least two tests or a z score = < -2.0 on at least one test. Results indicated that over 68% of patients were impaired with nearly a third of the sample showing impairment in verbal learning and memory and approximately one fifth showing impairments in aspects of executive function, processing speed, and visual learning. Ten percent of the patients endorsed symptoms indicative of a clinical level of depression. Medical comorbidities nor depression predicted cognitive impairment. These findings suggest that older adults candidates for HCT are at risk for cognitive impairment prior to transplant and thus cognition should be a consideration when developing treatment plans.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34031555     DOI: 10.1038/s41409-021-01331-9

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

1.  Management of cancer in the elderly: an essential need for more clinically relevant data.

Authors:  Maurie Markman
Journal:  Oncology       Date:  2013-08-30       Impact factor: 2.935

2.  Prospective evaluation of neurological complications after allogeneic bone marrow transplantation.

Authors:  P Sostak; C S Padovan; T A Yousry; G Ledderose; H-J Kolb; A Straube
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

3.  Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: a comparative study.

Authors:  Helena Harder; Arthur R Van Gool; Jan J Cornelissen; Hugo J Duivenvoorden; Wil M H Eijkenboom; Rene M Y Barge; Martin J van den Bent
Journal:  Eur J Cancer       Date:  2005-05       Impact factor: 9.162

4.  Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome.

Authors:  Christina A Meyers; Maher Albitar; Elihu Estey
Journal:  Cancer       Date:  2005-08-15       Impact factor: 6.860

5.  Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design.

Authors:  Melissa A Friedman; Mercedes Fernandez; Jeffrey S Wefel; Katherine A Myszka; Richard E Champlin; Christina A Meyers
Journal:  Arch Clin Neuropsychol       Date:  2009-09-18       Impact factor: 2.813

6.  Neuropsychologic impairment in adult bone marrow transplant candidates.

Authors:  M A Andrykowski; F A Schmitt; M E Gregg; M J Brady; D G Lamb; P J Henslee-Downey
Journal:  Cancer       Date:  1992-11-01       Impact factor: 6.860

7.  Predictors of neuropsychological change in patients with chronic myelogenous leukemia and myelodysplastic syndrome.

Authors:  Mary-Ellen Meadows; Grace Chang; Jennifer A Jones; Joseph R Antin; E John Orav
Journal:  Arch Clin Neuropsychol       Date:  2013-02-07       Impact factor: 2.813

8.  Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation.

Authors:  Helena Harder; Jan J Cornelissen; Arthur R Van Gool; Hugo J Duivenvoorden; Wil M H Eijkenboom; Martin J van den Bent
Journal:  Cancer       Date:  2002-07-01       Impact factor: 6.860

9.  The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.

Authors:  Jeffrey S Wefel; Renato Lenzi; Richard L Theriault; Robert N Davis; Christina A Meyers
Journal:  Cancer       Date:  2004-06-01       Impact factor: 6.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.